Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 1
2014 1
2016 1
2017 1
2018 3
2019 3
2021 1
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Efficient production of bispecific antibody by FAST-IgTM and its application to NXT007 for the treatment of hemophilia A.
Koga H, Yamano T, Betancur J, Nagatomo S, Ikeda Y, Yamaguchi K, Nabuchi Y, Sato K, Teranishi-Ikawa Y, Sato M, Hirayama H, Hayasaka A, Torizawa T, Haraya K, Sampei Z, Shiraiwa H, Kitazawa T, Igawa T, Kuramochi T. Koga H, et al. Among authors: kuramochi t. MAbs. 2023 Jan-Dec;15(1):2222441. doi: 10.1080/19420862.2023.2222441. MAbs. 2023. PMID: 37339067 Free PMC article.
Novel myostatin-specific antibody enhances muscle strength in muscle disease models.
Muramatsu H, Kuramochi T, Katada H, Ueyama A, Ruike Y, Ohmine K, Shida-Kawazoe M, Miyano-Nishizawa R, Shimizu Y, Okuda M, Hori Y, Hayashi M, Haraya K, Ban N, Nonaka T, Honda M, Kitamura H, Hattori K, Kitazawa T, Igawa T, Kawabe Y, Nezu J. Muramatsu H, et al. Among authors: kuramochi t. Sci Rep. 2021 Jan 25;11(1):2160. doi: 10.1038/s41598-021-81669-8. Sci Rep. 2021. PMID: 33495503 Free PMC article.
Characterizations of a neutralizing antibody broadly reactive to multiple gluten peptide:HLA-DQ2.5 complexes in the context of celiac disease.
Okura Y, Ikawa-Teranishi Y, Mizoroki A, Takahashi N, Tsushima T, Irie M, Harfuddin Z, Miura-Okuda M, Ito S, Nakamura G, Takesue H, Ozono Y, Nishihara M, Yamada K, Gan SW, Hayasaka A, Ishii S, Wakabayashi T, Muraoka M, Nagaya N, Hino H, Nemoto T, Kuramochi T, Torizawa T, Shimada H, Kitazawa T, Okazaki M, Nezu J, Sollid LM, Igawa T. Okura Y, et al. Among authors: kuramochi t. Nat Commun. 2023 Dec 22;14(1):8502. doi: 10.1038/s41467-023-44083-4. Nat Commun. 2023. PMID: 38135691 Free PMC article.
Engineering the variable region of therapeutic IgG antibodies.
Igawa T, Tsunoda H, Kuramochi T, Sampei Z, Ishii S, Hattori K. Igawa T, et al. Among authors: kuramochi t. MAbs. 2011 May-Jun;3(3):243-52. doi: 10.4161/mabs.3.3.15234. Epub 2011 May 1. MAbs. 2011. PMID: 21406966 Free PMC article. Review.
Antibody engineering to generate SKY59, a long-acting anti-C5 recycling antibody.
Sampei Z, Haraya K, Tachibana T, Fukuzawa T, Shida-Kawazoe M, Gan SW, Shimizu Y, Ruike Y, Feng S, Kuramochi T, Muraoka M, Kitazawa T, Kawabe Y, Igawa T, Hattori K, Nezu J. Sampei Z, et al. Among authors: kuramochi t. PLoS One. 2018 Dec 28;13(12):e0209509. doi: 10.1371/journal.pone.0209509. eCollection 2018. PLoS One. 2018. PMID: 30592762 Free PMC article.
Fc Engineering to Improve the Function of Therapeutic Antibodies.
Mimoto F, Kuramochi T, Katada H, Igawa T, Hattori K. Mimoto F, et al. Among authors: kuramochi t. Curr Pharm Biotechnol. 2016;17(15):1298-1314. doi: 10.2174/1389201017666160824161854. Curr Pharm Biotechnol. 2016. PMID: 27552846
15 results